The physiological roles of amyloid-beta peptide hint at new ways to treat Alzheimer's disease

Brothers, H, Gosztyla, M and Robinson, S 2018, 'The physiological roles of amyloid-beta peptide hint at new ways to treat Alzheimer's disease', Frontiers in Aging Neuroscience, vol. 10, pp. 1-16.


Document type: Journal Article
Collection: Journal Articles

Title The physiological roles of amyloid-beta peptide hint at new ways to treat Alzheimer's disease
Author(s) Brothers, H
Gosztyla, M
Robinson, S
Year 2018
Journal name Frontiers in Aging Neuroscience
Volume number 10
Start page 1
End page 16
Total pages 16
Publisher Frontiers Research Foundation
Abstract Amyloid-beta (A beta) is best known as the misfolded peptide that is involved in the pathogenesis of Alzheimer's disease (AD), and it is currently the primary therapeutic target in attempts to arrest the course of this disease. This notoriety has overshadowed evidence that A beta serves several important physiological functions. A beta is present throughout the lifespan, it has been found in all vertebrates examined thus far, and its molecular sequence shows a high degree of conservation. These features are typical of a factor that contributes significantly to biological fitness, and this suggestion has been supported by evidence of functions that are beneficial for the brain. The putative roles of A beta include protecting the body from infections, repairing leaks in the blood-brain barrier, promoting recovery from injury, and regulating synaptic function. Evidence for these beneficial roles comes from in vitro and in vivo studies, which have shown that the cellular production of A beta rapidly increases in response to a physiological challenge and often diminishes upon recovery. These roles are further supported by the adverse outcomes of clinical trials that have attempted to deplete A beta in order to treat AD. We suggest that anti-A beta therapies will produce fewer adverse effects if the known triggers of A beta deposition (e.g., pathogens, hypertension, and diabetes) are addressed first.
Subject Neurosciences not elsewhere classified
Biochemistry and Cell Biology not elsewhere classified
Keyword(s) Antimicrobial
ARIA
Cancer
Cerebrovascular
Immune system
Infection
Seizure
Traumatic injury
DOI - identifier 10.3389/fnagi.2018.00118
Copyright notice © 2018 Brothers, Gosztyla and Robinson. This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 License. (CC BY).
ISSN 1663-4365
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 13 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Altmetric details:
Access Statistics: 4 Abstract Views  -  Detailed Statistics
Created: Tue, 26 Mar 2019, 09:36:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us